| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5531359 | Cytotherapy | 2017 | 6 Pages |
Abstract
Our work represents a novel application of CS1-directed CAR T cells while revealing that BCMA would not be a suitable target. We expect AL to be particularly susceptible to CAR T-cell therapy because of the low tumor burden in the bone marrow.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Michael Rosenzweig, Ryan Urak, Miriam Walter, Laura Lim, James F. Sanchez, Amrita Krishnan, Stephen Forman, Xiuli Wang,